Add BrightSurf on Google Email

Science News for March 20, 2003


OHSU researchers identify ocular side effects of commonly prescribed drugs

A recent study published in the New England Journal of Medicine reveals that two types of medications used to treat osteoporosis and certain cancers can cause inflammation in the eyes, leading to vision loss or blindness if left untreated. The research found that almost 100 patients experienced blurred vision, pain, and swelling as a r...

SourceOregon Health & Science University·JournalNew England Journal of Medicine·DateMar 20, 2003

Ion trek through polymer offers better batteries

Researchers at Idaho National Laboratory have discovered a new polymer membrane that allows for more efficient movement of lithium ions, leading to better battery performance and longer lifespan. The membrane, made from MEEP material, can be molded into any shape and is temperature-tolerant, making it suitable for various applications.

SourceDOE/Idaho National Laboratory·JournalThe Journal of Physical Chemistry B·DateMar 20, 2003

Gold 'nanoplugs' wire up enzymes

Researchers have developed a technology that uses gold nanoparticles to attach enzymes to electrodes, improving the measurement of biological molecules. The technique enables more sensitive and specific glucose monitoring in diabetic patients, with higher flow rates detected than with traditional methods.

Is primary-care research a lost cause?

Researchers argue that primary care is misunderstood by academia and funding bodies, lacking a clear boundary to establish its distinct knowledge base. The editorial disagrees, emphasizing the importance of family practice in influencing all clinical specialties.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 20, 2003

First revised guidelines since 1994 on tuberculosis

The new guidelines recommend directly observed therapy for patients with TB to improve treatment completion rates. Four regimens are recommended for treating patients with drug-susceptible organisms, with an initial phase of 2 months followed by a continuation period of 4 to 7 months.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 20, 2003